G protein-coupled receptor (GPCR) trafficking in the central nervous system: Relevance for drugs of abuse

Drug and Alcohol Dependence

Volumn 51, Issue 1-2, 1998, Pages 73-85

  Roth, Bryan L ^a   Willins, David L ^a   Kroeze, Wesley K ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BRAIN RECEPTOR; CAVEOLIN; CLATHRIN; DYNAMIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; OPIATE; OPIATE RECEPTOR; PSYCHEDELIC AGENT; RAB PROTEIN; RETINA S ANTIGEN; SEROTONIN 2A RECEPTOR;

CENTRAL NERVOUS SYSTEM; DRUG ABUSE; ENDOCYTOSIS; ENDOSOME; HIPPOCAMPUS; HUMAN; INTERNALIZATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REVIEW; SPINAL NERVE;

EID: 0032104634     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(98)00067-2     Document Type: Article

References (150)

1. Anderson, R., 1993. Caveolae: where incoming and outgoing messengers meet. Proc. Natl. Acad. Sci. U.S.A. 90, 10909-10913.
2. Ando, A., Yonezawa, K., Gout, I., et al., 1994. A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment. EMBO. J. 13, 3033-3038.
3. Arden, J.R., Segredo, V., Wang, Z., Lameh, J., Sadee, W., 1995. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65, 1636-1645.
4. Attramadal, H., Arriza, J.L., Aoki, C., et al., 1992. beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J. Biol. Chem. 267, 17882-17890.
5. Aulakh, C.S., Mazzola-Pomietto, P., Hulihan-Giblin, B.A., Murphy, D.L., 1995. Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP suggests separate mediation by 5-HT2A and 5-HT2C receptors, respectively. Neuropsychopharmacology 13, 1-8.
6. Baumhaker, Y., Gafni, M., Keren, O., Sarne, Y., 1993. Selective and interactive down-regulation of mu-and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 44, 461-467.
7. Belcheva, M.M., Barg, J., McHale, R.J., et al., 1993. Differential down-and up-regulation of rat brain opioid receptor types and subtypes by buprenorphine. Mol. Pharmacol. 44, 173-179.
8. Belcheva, M.M., Barg, J., McHale, R., Coscia, C.J., 1994a. Naltrexone induces down-and upregulation of delta opioid receptors in rat brain regions. Brain Res. Bull. 35, 69-72.
9. Belcheva, M.M., Dawn, S., Barg, J., et al., 1994b. Transient down-regulation of neonatal rat brain mu-opioid receptors upon in utero exposure to buprenorphine. Brain Res. Dev. Brain Res. 80, 158-162.
10. Belcheva, M.M., Gucker, S., Chuang, D.M., et al., 1995. Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells. J. Pharmacol. Exp. Ther. 274, 1513-1523.
11. Belcheva, M.M., Ho, M.T., Ignatova, E.G., et al., 1996a. Buprenorphine differentially alters opioid receptor adaptation in rat brain regions. J. Pharmacol. Exp. Ther. 277, 1322-1327.
12. 125I-beta-endorphin cross-linked products in subcellular fractions from NG108-15 cells. Biochemistry 35, 14818-14824.
13. Bennett, D.B., Laskowski, M.B., Roth, B.L., Coscia, C.J., 1985. Stereospecific opiate binding sites occur in coated vesicles. J. Neurosci. 5, 3010-3015.
14. Berry, S.A., Khan, N., Roth, B.L., 1996. Rapid agonist-induced internalization of the 5-hydroxytryptamine 2A receptor occurs via the endosome pathway in vitro. Mol. Pharmacol. 50, 306-313.
15. Bucci, C., Parton, R., Mather, I., et al., 1992. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70, 715-728.
16. Buckholtz, N.S., Zhou, D.F., Freedman, D.X., Potter, W.Z., 1990. Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. Neuropsychopharmacology 3, 137-148.
17. Cameron, P.L., Ruffin, J.W., Bollag, R., Rasmussen, H., Cameron, R.S., 1997. Identification of caveolin and caveolin-related proteins in the brain. J. Neurosci. 17, 9520-9535.
18. Capeyrou, R., Riond, J., Corbani, M., Lepage, J.F., Bertin, B., Emorine, L.J., 1997. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain. FEBS Lett. 415, 200-205.
19. Carino, M.A., Chesnut, R.M., Weick, B.G., Horita, A., 1975. Tolerance development to central injection of LSD. Proc. West. Pharmacol. Soc. 18, 369-370.
20. Carino, M.A., Horita, A., 1977. Rapid development of tolerance upon central injection of LSD. Life Sci. 20, 49-55.
21. Chakrabarti, S., Yang, W., Law, P.Y., Loh, H.H., 1997. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation. Mol. Pharmacol. 52, 105-113.
22. Chan, K.W., Duttory, A., Yoburn, B.C., 1997. Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density. Eur. J. Pharmacol. 319, 225-228.
23. Chen, J.J., Dymshitz, J., Vasko, M.R., 1997. Regulation of opioid receptors in rat sensory neurons in culture. Mol. Pharmacol. 51, 666-673.
24. 3H]-ketanserin binding to 5-hydroxytryptamine2 receptors. Mol. Pharmacol. 43, 755-763.
25. Choudhary, M.S., Sachs, N., Uluer, A., Glennon, R.A., Westkaemper, R.B., Roth, B.L., 1995. Differential ergoline and ergopeptine binding to 5-hydroxytryptamine 2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. Mol. Pharmacol. 47, 450-457.
26. Chu, P., Murray, S., Lissin, D., von Zastrow, M., 1997. Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J. Biol. Chem. 272, 27124-27130.
27. Chuang, D.M., Carter, O., Spain, J.W., Laskowski, M.B., Roth, B.L., Coscia, C.J., 1986. Detection and characterization of beta-adrenergic receptors and adenylate cyclase in coated vesicles isolated from bovine brain. J. Neurosci. 6, 2578-2584.
28. Chun, M., Liyanage, U., Lisanti, M., Lodish, H., 1994. Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. USA 91, 11728-11732.
29. Clark, S.G., Shurland, D.L., Meyerowitz, E.M., Bargmann, C.I., van der Bliek, A.M., 1997. A dynamin GTPase mutation causes a rapid and reversible temperature-inducible locomotion defect in C. elegans. Proc. Natl. Acad. Sci. U.S.A. 94, 10438-10443.
30. Conner, D.A., Mathier, M.A., Mortensen, R.M., et al., 1997. Beta-arrestin1 knockout mice appear normal but then demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ. Res. 81, 1021-1026.
31. Cvejic, S., Devi, L.A., 1997. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J. Biol. Chem. 272, 26959-26964.
32. Cvejic, S., Trapaidze, N., Cyr, C., Devi, L.A., 1996. Thr353, located within the COOH-terminal tail of the delta opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271, 4073-4076.
33. Damke, H., 1996. Dynamin and receptor-mediated endocytosis. FEBS Lett. 389, 48-51.
34. de Hoop, M.J., Huber, L.A., Stenmark, H., et al., 1994. The involvement of the small GTP-binding protein Rab5a in neuronal endocytosis. Neuron 13, 11-22.
35. de Weerd, W.F., Leeb-Lundberg, L.M., 1997. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled G alpha subunits G alpha q and G alpha i in caveolae in DDT1 MF-2 smooth muscle cells. J. Biol. Chem. 272, 17858-17866.
36. Diaz, A., Ruiz, F., Florez, J., Hurle, M.A., Pazos, A., 1995. Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J. Pharmacol. Exp. Ther. 274, 1545-1551.
37. Feng, Y., Press, B., Wadinger-Ness, A., 1995. Rab7: an important regulator of late endocytic membrane traffic. J. Cell. Biol. 131, 1435-1452.
38. Ferguson, S., III, W.D., Colapietro, A.-M., Barak, L., Menard, L., Caron, M., 1996a. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271, 363-366.
39. Ferguson, S.S., Barak, L.S., Zhang, J., Caron, M.G., 1996b. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74, 1095-1110.
40. Ferguson, S.S., Zhang, J., Barak, L.S., Caron, M.G., 1996c. G-protein-coupled receptor kinases and arrestins: regulators of G-protein-coupled receptor sequestration. Biochem. Soc. Trans. 24, 953-959.
41. Feron, O., Smith, T.W., Michel, T., Kelly, R.A., 1997. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J. Biol. Chem. 272, 17744-17748.
42. Ferry, R.C., Molinoff, P.B., 1996. Regulation of 5-HT2A receptor mRNA in P11 cells. Behav. Brain. Res. 73, 187-191.
43. Ferry, R.C., Unsworth, C.D., Molinoff, P.B., 1993. Effects of agonists, partial agonists, and antagonists on the regulation of 5-hydroxytryptamine2 receptors in P11 cells. Mol. Pharmacol. 43, 726-733.
44. Ferry, R.C., Unsworth, C.D., Artymyshyn, R.P., Molinoff, P.B., 1994. Regulation of mRNA encoding 5-HT2A receptors in P11 cells through a post-transcriptional mechanism requiring activation of protein kinase C. J. Biol. Chem. 269, 31850-31857.
45. Gaudriault, G., Nouel, D., Dal Farra, C., Beaudet, A., Vincent, J.P., 1997. Receptor-induced internalization of selective peptidic mu and delta opioid ligands. J. Biol. Chem. 272, 2880-2888.
46. Gonzalez-Calero, G., Martin, M., Cubero, A., Andres, A., 1990. Bovine brain coated vesicles contain adenosine A1 receptors. Presence of adenylate cyclase coupled to the receptor. J. Neurochem. 55, 106-113.
47. Gonzalez-Calero, G., Cubero, A., Klotz, K., 1992. G-protein-coupled A1 adenosine receptors in coated vesicles of mammalian brain: characterization by radioligand binding and photoaffinity labelling. Cell Signal. 4, 737-745.
48. Goodman, O., Krupnick, J., Gurevich, V., Benovic, J., Keen, J., 1997. Arrestin/clathrin interactions: localization of the arrestin binding locus to the clathrin terminal domain. J. Biol. Chem. 272, 15017-15022.
49. Goodman, O., Krupnick, J., Santini, F., et al., 1996. β-arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor. Nature 383, 447-450.
50. Gorodinski, A., Harris, D., 1995. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J. Cell. Biol. 129, 619-627.
51. Grady, E.F., Gamp, P.D., Jones, E., et al., 1996. Endocytosis and recycling of neurokinin 1 receptors in enteric neurons. Neuroscience 75, 1239-1254.
52. Hazum, E., Koch, Y., Liscovitch, M., Amsterdam, A., 1985. Intracellular pathways of receptor-bound GnRH agonist in pituitary gonadotropes. Cell Tissue. Res. 239, 3-8.
53. Herskovits, J.S., Burgess, C.C., Obar, R.A., Vallee, R.B., 1993. Effects of mutant rat dynamin on endocytosis. J. Cell. Biol. 122, 565-578.
54. Hoffenberg, S.S., Shaobin, J.C., Daniel, D.S., et al., 1995. Biochemical and functional characterization of a recombinant GTPase, rab5, and two of its mutants. J. Biol. Chem. 270, 5048-5056.
55. Ivins, K.J., Molinoff, P.B., 1990. Serotonin-2 receptors coupled to phosphoinositide hydrolysis in a clonal cell line. Mol. Pharmacol. 37, 622-630.
56. Ivins, K.J., Molinoff, P.B., 1991. Desensitization and down-regulation of 5-HT2 receptors in P11 cells. J. Pharmacol. Exp. Ther. 259, 423-429.
57. Jakab, R.L., Goldman-Rakic, D.S., 1998. 5-hydroxytryptamine 2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc. Natl. Acad. Sci. USA 95, 735-740.
58. Jonas, S., Downer, J.d.C., 1964. Gross behavioural changes in monkeys following administration of LSD-25, and development of tolerance to LSD-25. Psychopharmacologia 6, 303-306.
59. Kagaya, A., Mikuni, M., Kusumi, I., Yamamoto, H., Takahashi, K., 1990. Serotonin-induced acute desensitization of serotonin2 receptors in human platelets via a mechanism involving protein kinase C. J. Pharmacol. Exp. Ther. 255, 305-311.
60. Kagaya, A., Mikuni, M., Muraoka, S., et al., 1993. Homologous desensitization of serotonin 5-HT2 receptor-stimulated intracellular calcium mobilization in C6BU-1 glioma cells via a mechanism involving a calmodulin pathway. J. Neurochem. 61, 1050-1056.
61. Keith, D.E., Murray, S.R., Zaki, P.A., et al., 1996. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024.
62. Kim, D.S., Chin, H., Klee, W.A., 1995. Agonist regulation of the expression of the delta opioid receptor in NG108-15 cells. FEBS Lett. 376, 11-14.
63. Knoll, J., Vizi, E.S., 1970. Cross-tolerance between para-bromomethamphetamine (V-111) and LSD-25. Pharmacology 4, 278-286.
64. Kornilova, E., Sorkina, T., Beguinot, L., Sorkin, A., 1996. Lysosomal targeting of epidermal growth factor receptors via a kinase-dependent pathway is mediated by the receptor carboxyl-terminal residues 1022-1123. J. Biol. Chem. 271, 30340-30346.
65. Krebs, K.M., Geyer, M.A., 1994. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats. Psychopharmacology (Berlin) 113, 429-437.
66. Krupnick, J., Goodman, O., Keen, J., Benovic, J., 1997. Arrestin/clathrin interaction: localization of the clathrin binding domain of nonvisual arrestins to the carboxyl terminus. J. Biol. Chem. 272, 15011-15016.
67. Law, P.Y., Hom, D.S., Loh, H.H., 1984. Down-regulation of opiate receptor in neuroblastoma x glioma NG108-15 hybrid cells. Chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J. Biol. Chem. 259, 4096-4104.
68. Leysen, J.E., Pauwels, P.J., 1990. 5-HT2 receptors, roles and regulation. Ann. N.Y. Acad. Sci., 600:183-191; discussion 192-193.
69. Leysen, J.E., Janssen, P.F., Niemegeers, C.J., 1989. Rapid desensitization and down-regulation of 5-HT2 receptors by DOM treatment. Eur. J. Pharmacol. 163, 145-149.
70. Li, S., Okamoto, T., Chun, M., et al., 1995. Evidence for a regulated interaction between heterotrimeric G protein and caveolin. J. Biol. Chem. 270, 15693-15701.
71. Lisanti, M., Scherer, P., Tang, Z., Sargiacomo, M., 1994. Caveolae, caveolin, and caveolin rich membrane domains: a signaling hypothesis. Trends Cell. Biol. 4, 231-235.
72. Loh, H.H., Tao, P.L., Smith, A.P., 1988. Role of receptor regulation in opioid tolerance mechanisms. Synapse 2, 457-462.
73. Lohse, M.J., Benovic, J.L., Codina, J., Caron, M.G., Lefkowitz, R.J., 1990. Beta-arrestin: a protein that regulates beta-adrenergic receptor function. Science 248, 1547-1550.
74. Mantyh, P.W., Allen, C.J., Ghilardi, J.R., et al., 1995a. Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc. Natl. Acad. Sci. U.S.A. 92, 2622-2626.
75. Mantyh, P.W., DeMaster, E., Malhotra, A., et al., 1995b. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 268, 1629-1632.
76. Martin, M., Sanz, J., Cubero, A., 1993. Characterization of metabotropic glutamate receptors coupled to a pertussis toxin sensitive G-protein in bovine brain coated vesicles. FEBS Lett. 316, 191-196.
77. Mazzola-Pomietto, P., Aulakh, C.S., Wozniak, K.M., Hill, J.L., Murphy, D.L., 1995. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology (Berlin) 117, 193-199.
78. Mazzola-Pomietto, P., Aulakh, C.S., Huang, S.J., Murphy, D.L., 1996a. Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats. J. Pharmacol. Exp. Ther. 279, 782-789.
79. Mazzola-Pomietto, P., Aulakh, C.S., Wozniak, K.M., Murphy, D.L., 1996b. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology (Berlin) 123, 333-339.
80. McClure, S.J., Robinson, P.J., 1996. Dynamin, endocytosis and intracellular signalling (review). Mol. Membr. Biol. 13, 189-215.
81. McKenna, D.J., Nazarali, A.J., Himeno, A., Saavedra, J.M., 1989. Chronic treatment with ( + / - )DOI, a psychotomimetic 5-HT2 agonist, downregulates 5-HT2 receptors in rat brain. Neuropsychopharmacology 2, 81-87.
82. McPherson, P.S., Czernik, A.J., Chilcote, T.J., et al., 1994. Interaction of Grb2 via its Src homology 3 domains with synaptic proteins including synapsin I. Proc. Natl. Acad. Sci. U.S.A. 91, 6486-6490.
83. Menard, L., Ferguson, S.S., Zhang, J., et al., 1997. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization. Mol. Pharmacol. 51, 800-808.
84. Miki, H., Miura, K., Matuoka, K., et al., 1994. Association of Ash/Grb-2 with dynamin through the Src homology 3 domain. J. Biol. Chem. 269, 5489-5492.
85. Moore, R., Sadovnikoff, N., Hoffenberg, S., et al., 1995. Ligand-stimulated beta 2-adrenergic receptor internalization via the constitutive endocytic pathway into rabS-containing endosomes. J. Cell. Sci. 108, 2983-2991.
86. Nishino, K., Su, Y.F., Wong, C.S., Watkins, W.D., Chang, K.J., 1990. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord. J. Pharmacol. Exp. Ther. 253, 67-72.
87. Obar, R.A., Collins, C.A., Hammarback, J.A., Shpetner, H.S., Vallee, R.B., 1990. Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins. Nature 347, 256-261.
88. Olive, S., Dubois, C., Schachner, M., Rougon, G., 1995. The F3 neuronal glycosylphosphatidylinositol-linked molecule is localized to glycolipid-enriched membrane subdomains and interacts with L1 and Fyn kinase in cerebellum. J. Neurochem. 65, 2307-2317.
89. Olkkonen, V., Stenmark, H., 1997. Role of Rab GTPases in membrane traffic. Int. Rev. Cytol. 176, 1-85.
90. Ozaki, N., Moroi, K., Kadota, T., Suzuki, S., Kadota, K., 1994. Dopamine D1 and D2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue. J. Neurochem. 62, 582-591.
91. Parton, R.G., 1996. Caveolae and caveolins. Curr. Opin. Cell. Biol. 8, 542-548.
92. Patrini, G., Massi, P., Ricevuti, G., et al., 1996. Changes in opioid receptor density on murine splenocytes induced by in vivo treatment with morphine and methadone. J. Pharmacol. Exp. Ther. 279, 172-176.
93. Pauwels, P.J., Von Gompel, P., Leysen, J.E., 1990. Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. Life Sci. 47, 2009-2019.
94. Pearse, B.M., Bretscher, M.S., 1981. Membrane recycling by coated vesicles. Annu. Rev. Biochem. 50, 85-101.
95. Pert, C.B., Snyder, S.H., 1973. Opiate receptor: demonstration in nervous tissue. Science 179, 1011-1014.
96. Petruzzi, R., Ferraro, T.N., Kurschner, V.C., Golden, G.T., Berrettini, W.H., 1997. The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice. Life Sci. 61, 2057-2064.
97. Pippig, S., Andexinger, S., Lohse, M., 1995. Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol. Pharmacol. 47, 666-676.
98. Polastron, J., Meunier, J.C., Jauzac, P., 1994. Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit. Eur. J. Pharmacol. 266, 139-146.
99. Rahman, S., Neuman, R.S., 1993. Multiple mechanisms of serotonin 5-HT2 receptor desensitization. Eur. J. Pharmacol. 238, 173-180.
100. Ramaswami, M., Rao, S., van der Bliek, A., Kelly, R.B., Krishnan, K.S., 1993. Genetic studies on dynamin function in Drosophila. J. Neurogenet. 9, 73-87.
101. Rech, R.H., Tilson, H.A., Marquis, W.J., 1975. Adaptive changes in behavior after repeated administration of various psychoactive drugs. Adv. Biochem. Psychopharmacol. 13, 263-286.
102. Riezman, H., Woodman, P., van Meer, G., Marsh, M., 1997. Molecular mechanisms of endocytosis. Cell 91, 731-738.
103. Rinaldi-Carmona, M., Prabonnaud, V., Bouaboula, M., et al., 1994. Regulation of 5-hydroxytryptamine2 (5-HT2) receptor expression in cultured rat aortic smooth muscle cells by SR 46349B, a selective 5-HT2 receptor antagonist. J. Biol. Chem. 269, 396-401.
104. Robinson, M., 1994. The role of clathrin, adaptors and dynamin in endocytosis. Curr. Opin. Cell. Biol. 6, 538-544.
105. Robinson, P.J., Liu, J.P., Powell, K.A., Fykse, E.M., Sudhof, T.C., 1994. Phosphorylation of dynamin I and synaptic-vesicle recycling. Trends Neurosci. 17, 348-353.
106. Roettger, B.F., Rentsch, R.U., Pinon, D., et al., 1995. Dual pathways of internalization of the cholecystokinin receptor. J. Cell. Biol. 128, 1029-1041.
107. Roettger, B.G., Rao, D., Toledo, C., Yingling, J., Pinon, D., Miller, L.J., 1997. Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol. Pharmacol. 51, 357-362.
108. Ronnekleiv, O.K., Bosch, M.A., Cunningham, M.J., Wagner, E.J., Grandy, D.K., Kelly, M.J., 1996. Downregulation of mu-opioid receptor mRNA in the mediobasal hypothalamus of the female guinea pig following morphine treatment. Neurosci. Lett. 216, 129-132.
109. Roth, B.J., Coscia, C.J., 1984. Microsomal opiate receptors: characterization of smooth microsomal and synaptic membrane opiate receptors. J. Neurochem. 42, 1677-1684.
110. Roth, B.L., Laskowski, M.B., Coscia, C.J., 1981. Evidence for distinct subcellular sites of opiate receptors. Demonstration of opiate receptors in smooth microsomal fractions isolated from rat brain. J. Biol. Chem. 256, 10017-10023.
111. Roth, B.L., Laskowski, M.W., Coscia, C.J., 1982. Microsomal opiate receptors differ from synaptic membrane receptors in proteolytic sensitivity. Brain Res. 250, 101-109.
112. Roth, B.L., Hamblin, M., Ciaranello, R.D., 1990. Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms. Neuropsychopharmacology 3, 427-433.
113. Roth, B., Palvimaki, E.-P., Berry, S., et al., 1995. 5-Hydroxytryptamine2A (5-HT2A) receptor desensitization can occur without down-regulation. J. Pharmacol. Exp. Ther. 275, 1638-1646.
114. Roth, B.L., Choudhary, M.S., Khan, N., Uluer, A.Z., 1997. High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model. J. Pharmacol. Exp. Ther. 280, 576-583.
115. Roth, B., Willins, D., Kristiansen, K., Kroeze, W., in press. 5-HT2-family receptors (5-HT2A, 5-HT2B, 5-HT2C): where structure meets function. Pharmacol. Ther.
116. Rothman, R.B., Brady, L.S., Xu, H., Long, J.B., 1993. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain. Peptides 14, 1271-1277.
117. Saucier, C., Albert, P.R., 1997. Identification of an endogenous 5-hydroxytryptamine2A receptor in NIH-3T3 cells: agonist-induced down-regulation involves decreases in receptor RNA and number. J. Neurochem. 68, 1998-2011.
118. Scaife, R., Margolis, R.L., 1990. Biochemical and immunochemical analysis of rat brain dynamin interaction with microtubules and organelles in vivo and in vitro. J. Cell. Biol. 111, 3023-3033.
119. Scaife, R., Gout, I., Waterfield, M.D., Margolis, R.L., 1994. Growth factor-induced binding of dynamin to signal transduction proteins involves sorting to distinct and separate proline-rich dynamin sequences. Embo. J. 13, 2574-2582.
120. Schmid, S., 1997. Clathrin-coated vesicle formation and protein sorting: an integrated process. In: Annu. Rev. Biochem., vol. 66. Annual Reviews, Palo Alto, CA, pp. 511-548.
121. Shpetner, H.S., Vallee, R.B., 1989. Identification of dynamin, a novel mechanochemical enzyme that mediates interactions between microtubules. Cell 59, 421-432.
122. Silva, W., Andres, A., Schook, W., Puszkin, S., 1986. Evidence for the presence of muscarinic acetylcholine receptors in bovine brain coated vesicles. J. Biol. Chem. 261, 14788-14796.
123. Song, S.K., Li, S., Okamoto, T., Quilliam, L.A., Sargiacomo, M., Lisanti, M.P., 1996. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271, 9690-9697.
124. Sontag, J.M., Fykse, E.M., Ushkaryov, Y., Liu, J.P., Robinson, P.J., Sudhof, T.C., 1994. Differential expression and regulation of multiple dynamins. J. Biol. Chem. 269, 4547-4554.
125. Spain, J.W., Petta, D.E., Coscia, C.J., 1986. A comparison of microsomal and synaptic delta site binding kinetics. NIDA Res. Monogr. 75, 109-112.
126. Spain, J.W., Petta, D.E., Coscia, C.J., 1988. Binding kinetics of delta opioid receptors differ for microsomal and synaptic sites. Mol. Pharmacol. 34, 23-28.
127. Stenmark, H., Parton, R.G., Steele-Mortimer, O., Lutcke, A., Gruenberg, J., Zerial, M., 1994. Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO. J. 13, 1287-1296.
128. Stenmark, H., Vitale, G., Ullrich, O., Zerial, M., 1995. Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion. Cell 83, 423-432.
129. Sternini, C., Spann, M., Anton, B., et al., 1996. Agonist-selective endocytosis of mu opioid receptor by neurons in vivo. Proc. Natl. Acad. Sci. U.S.A. 93, 9241-9246.
130. Szucs, M., Coscia, C.J., 1992. Differential coupling of opioid binding sites to guanosine triphosphate binding regulatory proteins in subcellular fractions of rat brain. J. Neurosci. Res. 31, 565-572.
131. Tehrani, M., Barnes, E., Jr., 1993. Identification of GABAA/benzodiazepine receptors on clathrin-coated vesicles from rat brain. J. Neurochem. 60, 1755-1761.
132. Thompson, A.K., Fisher, S.K., 1990. Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulation phosphoinositide turnover in two neuroblastomas: methodological considerations. J. Pharmacol. Exp. Ther. 252, 744-745.
133. Torre, E., McNiven, M.A., Urrutia, R., 1994. Dynamin 1 antisense oligonucleotide treatment prevents neurite formation in cultured hippocampal neurons. J. Biol. Chem. 269, 32411-32417.
134. Trapaidze, N., Keith, D.E., Cvejic, S., Evans, C.J., Devi, L.A., 1996. Sequestration of the delta opioid receptor. Role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271, 29279-29285.
135. Urrutia, R., Henley, J.R., Cook, T., McNiven, M.A., 1997. The dynamins: redundant or distinct functions for an expanding family of related GTPases? Proc. Natl. Acad. Sci. U.S.A. 94, 377-384.
136. Vallee, R.B., Shpetner, H.S., 1990. Motor proteins of cytoplasmic microtubules. Annu. Rev. Biochem. 59, 909-932.
137. Vallee, R.B., Herskovits, J.S., Aghajanian, J.G., Burgess, C.C., Shpetner, H.S., 1993. Dynamin, a GTPase involved in the initial stages of endocytosis. J. Cell. Sci. 105, 1-5.
138. van der Bliek, A.M., Meyerowitz, E.M., 1991. Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic. Nature 351, 411-414.
139. van Huizen, F., Bansse, M.T., Stam, N.J., 1993. Agonist-induced down-regulation of human 5-HT1A and 5-HT2 receptors in Swiss 3T3 cells. Neuroreport 4, 1327-1330.
140. Vouret-Craviari, V., Auberger, P., Pouyssegur, J., Obberghen-Schilling, E., 1995. Distinct mechanisms regulate 5-HT2 and thrombin receptor desensitization. J. Biol. Chem. 270, 4813-4821.
141. Wedegaertner, P.B., Bourne, H.R., von Zastrow, M., 1996. Activation-induced subcellular redistribution of Gs alpha. Mol. Biol. Cell. 7, 1225-1233.
142. Willins, D., Deutch, A., Roth, B., 1997. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27, 79-82.
143. Willins, D., Alsayegh, L., Berry, S., Backstrom, J., Sanders-Bush, E., Friedman, L., Kahn, N., Roth, B., in press. Serotonergic antagonist effects on trafficking of serotonin 5-HT2A receptors in vitro and in vivo.
144. Winter, J.C., 1971. Tolerance to a behavioral effect of lysergic acid diethylamide and cross-tolerance to mescaline in the rat: absence of a metabolic component. J. Pharmacol. Exp. Ther. 178, 625-630.
145. Wu, C., Butz, S., Ying, Y., Anderson, R.G., 1997. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J. Biol. Chem. 272, 3554-3559.
146. Yabaluri, N., Medzihradsky, F., 1997. Down-regulation of mu-opioid receptor by full but not partial agonists is independent of G protein coupling. Mol. Pharmacol. 52, 896-902.
147. Yoburn, B.C., Billings, B., Duttaroy, A., 1993. Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther. 265, 314-320.
148. Zadina, J.E., Harrison, L.M., Ge, L.J., Kastin, A.J., Chang, S.L., 1994. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 270, 1086-1096.
149. Zhang, J., Barak, L.S., Winkler, K.E., Caron, M.G., Ferguson, S.S.G., 1997. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types. J. Biol. Chem. 272, 27005-27014.
150. Zhao, G.M., Bhargava, H.N., 1997. Effects of multiple intracerebroventricular injections of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin II on tolerance to their analgesic action and on brain delta-opioid receptors. Brain Res. 745, 243-247.